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Background/Aims: There are limited data regarding the clin-
ical outcomes of self-expandable metal stents in the treat-
ment of proximal colon obstruction. We compared the clini-
cal outcomes of stent placement in patients with malignant 
proximal to distal colon obstructions. Methods: We reviewed 
medical records from 37 consecutive patients from three in-
stitutions (19 men; mean age, 72 years) who underwent en-
doscopic stent placement at a malignant obstruction of the 
proximal colon. We also examined the records from 99 pa-
tients (50 men; mean age, 65 years) who underwent endo-
scopic stent placement for a distal colon obstruction. Techni-
cal success, clinical improvements, complications and stent 
patency were compared between treatments. Results: The 
technical success rate tended to be lower in stents inserted 
to treat proximal colon obstructions than in those used to 
treat distal colon obstructions (86% vs 97%, p=0.06). Clinical 
improvement was achieved in 78% of patients (29/37) with 
proximal colonic stenting and in 91% of patients (90/99) 
with distal colonic stenting (p=0.08). Complications (24% vs 
27%), stent migration (8% vs 8%) and stent reocclusion rates 
(11% vs 17%) did not differ signiﬁ  cantly between groups. Two 
cases of bowel perforation related to stenting (5%) occurred 
in patients with proximal colonic stenting. Conclusions: The 
technical success and clinical improvement associated with 
self-expandable metal stents used to treat proximal colon 
obstruction tend to be lower than cases of distal colon ob-
struction. Technical failure is an important cause of poor 
clinical improvement in patients with proximal colon stenting. 
Complication rates and stent patency appear to be similar in 
both groups. (Gut Liver 2011;5:165-170)
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INTRODUCTION
Placement of a self-expandable metal stent (SEMS) is a safe 
and effective treatment for left-sided malignant colorectal ob-
struction, for palliation, or for allowing a single-stage resection.
1 
Recent reviews have reported technical and clinical success rates 
of greater than 90% and low rates of complications including 
stent migration (10% to 12%), stent blockage (7% to 10%) and 
perforation (3% to 4%).
2,3 Most of these data were from proce-
dures to insert an SEMS for a distal colon obstruction. However, 
there are limited data regarding stent placement for proximal 
colon obstruction because fewer than 5% of reported cases have 
involved this region.
4,5 The main reason for the limited data 
on stent placement in the right colon is that this type of acute 
obstruction is usually handled by resection and primary anasto-
mosis without the need for formal bowel preparation.
6
Since the first report on stent placement in the transverse co-
lon in 1997,
7 a few studies have discussed the clinical outcomes 
of the use of stents in the management of proximal colon ob-
struction.
6,8–11 These studies reported that stent placement for a 
proximal colon obstruction is a safe, feasible and effective treat-
ment for palliation or as a bridge to surgery. However, long-
term follow-up data on complications and stent patency are 
limited.
We evaluated the feasibility and efficacy of endoscopic stent 
insertion to treat proximal colon obstructions caused by pri-
mary colon cancer. We compared the technical feasibility and 
clinical outcomes of SEMS insertion for treating proximal colon 
obstruction with those for distal colon obstruction.
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MATERIALS AND METHODS
1. Subjects
The data for 37 consecutive patients who had documented 
primary colon adenocarcinoma and underwent endoscopic stent 
insertion for colon obstruction proximal to the splenic flexure at 
three institutions (Seoul St. Mary’s Hospital, St. Vincent’s Hospi-
tal, and Incheon St. Mary’s Hospital, Korea) were compared with 
those of 99 consecutive patients who underwent endoscopic 
stent insertion for malignant distal colon obstruction at Seoul 
St. Mary’s Hospital from January 2004 to March 2009. SEMSs 
were inserted for palliative treatment or as a bridge to curative 
surgery. Patients with colon obstruction caused by other than 
colorectal malignancies were excluded from this study.
This study was performed by retrospective review. Data were 
gathered on patient age and sex, use of SEMS for palliation or 
bridge to surgery, type of stent, stent diameter and length, loca-
tion of any obstruction, use of chemotherapy or radiotherapy 
after stent placement, type of surgery, surgical complications 
and outcomes and survival rate. Patients were considered to 
have subtotal obstruction if they manifested symptoms such as 
bowel distension, difficulty in passing solid stool or presence of 
narrowed stool caliber, or the ability to only pass small amounts 
of liquid stool or gas. Patients were considered to have complete 
obstruction if they presented with nausea, vomiting, abdominal 
distension, decreased or absent bowel sounds, or the inability to 
pass any stool or gas per anus.
All patients displayed clinical features and symptoms of 
colorectal obstruction. All patients had endoscopic features of 
colonic obstruction and a colonoscope of 12 to 14 mm diameter 
could not pass through the stricture.
2. Endoscopic stent placement
Eighty-four Hanaro
⡴ stents (M. I. Tech Co. Ltd., Seoul, Ko-
rea) and 52 Bona
⡴ stents (Standard Sci-Tech Inc., Seoul, Korea) 
were used. These were 22 to 24 mm in diameter and 6 to 16 cm 
long. Bowel preparation was performed using repeated sodium 
phosphate enemas for patients with total bowel obstruction 
or polyethylene glycol for some patients with subtotal bowel 
obstruction. Under endoscopic and fluoroscopic guidance, 
an endoscopic retrograde cholangiopancreatography (ERCP) 
catheter was passed over the guidewire, through the stricture, 
and advanced to the proximal region. The guidewire was then 
removed and a contrast dye was injected through the catheter 
to define the degree, length and site of the stricture. After that, 
a guidewire was reintroduced through the stricture. The SEMS, 
preloaded into a delivery system, was advanced over the guide-
wire and positioned through the stricture under endoscopic and 
fluoroscopic guidance. The stent was then released and its posi-
tion and location were assessed.
Patients started an oral diet after they had passed flatus and 
the symptoms of obstruction had improved. Endoscopic or ra-
diological follow-up evaluation was performed only in those 
patients with recurrent obstructive symptoms.
3. Deﬁ  nitions
Outcomes of SEMS placement were evaluated according to 
the following parameters: 1) technical success, 2) clinical im-
provement, 3) complications, and 4) stent patency. Technical 
success was defined as accurate placement of the stent through 
the entire length of stricture. Clinical improvement was defined 
as the ability of the patient to defecate and the relief of obstruc-
tive symptoms without procedure-related complications. Stent 
patency was defined as the period between the initial stent 
placement and the recurrence of obstructive symptoms caused 
by a stent occlusion.
4. Statistical analysis
Continuous variables for patient characteristics are expressed 
as the mean±SD. The percentage of patients for whom stenting 
was performed as a bridge to surgery, the technical success rate 
and the clinical outcomes of proximal colonic stenting and dis-
tal colonic stenting were compared using chi-squared tests. The 
overall survival and stent patency were estimated using Kaplan–
Meier life table analysis.
Table 1. Clinical Characteristics of Patients Who Underwent Stent 
Placement for Proximal or Distal Colon Obstruction
Proximal 
colon stent
Distal 
colon stent
No. of patients 37 99
Male:Female 19:18 50:49
Mean age, yr 72±11  65±11 
Stent for the bridge to surgery   10 (27) 30 (30)
Site of obstruction
    Ascending colon 12
    Hepatic flexure 11
    Transverse colon 14
    Splenic flexure 2
    Descending colon 9
    Sigmoid colon 49
    Rectum 39
Complete colon obstruction 18 (50) 80 (80)
Stent type
    Hanaro
⡴ stent 30 54 
    Bona
⡴ stent    7 45
Uncovered stent  30 (81) 94 (97)
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RESULTS
1. Patient characteristics
The patients’ characteristics are summarized in Table 1. Dur-
ing the study period, stenting was attempted in 37 patients with 
colon obstruction proximal to the splenic flexure and in 99 pa-
tients with distal colon obstruction. Left-sided colon obstruction 
including the splenic flexure was regarded as the distal colon. 
The site of obstruction was the ascending colon (n=12), hepatic 
flexure (n=11), transverse colon (n=14), splenic flexure (n=2), 
descending colon (n=9), and rectosigmoid colon (n=88). Colon 
obstruction was complete in 18 patients (49%) and subtotal in 
19 patients. Stenting was attempted as a bridge to surgery in 10 
patients (27%) treated with proximal colonic stenting and in 30 
patients (30%) treated with distal colonic stenting. These distri-
butions were not significantly different (p=0.90). 
2. Technical and clinical outcomes
The technical and clinical outcomes are summarized in Table 
2. Technical success was achieved in 86% (32/37) of patients 
with proximal colon obstruction and in 97% (96/99) of patients 
with distal colon obstruction (p=0.06). The causes of techni-
cal failure of proximal colonic stenting were inability to pass 
the guidewire through the completely obstructed site (n=1), a 
bowel perforation related to stenting (n=1), stent expansion 
failure (n=2), and stent malposition (n=1). The causes of techni-
cal failure in patients receiving left colonic stenting were stent 
malposition (n=1), inadequate length of the stent for traversing 
the lesion (n=1) and stent expansion failure (n=1). There was no 
procedure-related mortality.
One case of immediate bowel perforation was caused by a 
stent passing through the wall of the ascending colon during 
insertion. There were two cases of stent expansion failure in pa-
tients with proximal colon obstructions. The first was a patient 
with ascending colon obstruction. Her obstructive symptoms did 
not improve and ileus persisted despite stent placement. Delayed 
bowel perforation was recognized six days after stent place-
ment. She was treated with an emergency palliative operation. 
The second case was a patient with a transverse colon obstruc-
tion. Immediately after stenting, dilatation using a CRE
TM Bal-
loon (Boston Scientific Co., Boston, MA, USA) was performed 
because the initial expansion of the stent was unsatisfactory. 
Bowel perforation was recognized during the balloon dilatation. 
She was treated with surgery.
In summary, there were three cases of bowel perforation in 
patients who had proximal colon obstructions. One case was 
immediate and one was a delayed bowel perforation related to 
stenting. One case was not related to stenting. The demographic 
and procedural details for these patients are listed in Table 3. 
Table 2. Initial Technical Success and Clinical Improvement Follow-
ing Stent Placement
Proximal 
colon 
stent
(n=37)
Distal 
colon 
stent
(n=99)
p-
value
Initial technical success 32 (86) 96 (97) 0.06
Clinical improvement  29 (78) 90 (91) 0.08
Causes of technical or clinical failure
  Inability to pass the guidewire 1
  Immediate bowel perforation  1
  Stent malposition  1 1
  Stent expansion failure 2 1
  Inadequate length of stent 1
  Early stent migration* 1 2
  Multifocal stricture* 2 1
  Early stent reocclusion* 2
  Impacted stool within stent* 1
Data are presented as number (%).
*These occurred in patients whose stents were inserted successfully.
Table 3. Demographics, Procedure Details, and Outcomes in 3 Patients with Bowel Perforations
No. Age/Sex
Obstruction 
location
Stent size, 
mm
Used
stent
Carcino-
matosis
Outcomes
1 57/M Ascending colon 22×8 Hanaro No Immediate bowel perforation
 2* 85/F Ascending colon 22×8 Hanaro Yes Delayed bowel perforation 
 3* 84/ F Transverse colon   22×12 Hanaro No Bowel perforation by balloon dilatation followed by placement of stent
*Initial stent expansion failed in those patients.
Table 4. Stent Related Complications in Proximal and Distal Colon 
Stent Placement
Proximal 
colon stent
(n=37)
Distal 
colon stent 
(n=99)
p-value
Complications  9 (24) 27 (27) 0.89
Bowel perforation 2 (5) 0 0.15
Stent reocclusion 4 (11) 18 (18) 0.47
(median time, range)  (64 days, 
19-930 days)
 (162 days, 
4-429 days)
0.55
Stent migration 3 (8) 8 (8) 0.73
Stent disruption 0 2
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None of the patients with distal colon obstruction had bowel 
perforation.
Stent malposition occurred in a patient with excessive angu-
lated obstruction at the hepatic flexure. A case of failure to pass 
the guidewire though the obstructive lesion also occurred in 
another patient who had obstruction at the hepatic flexure.
Clinical improvement was achieved in 78% (29/37) of pa-
tients with proximal colonic stenting. Three patients whose stent 
had been successfully inserted did not improve because of early 
stent migration (n=1) or combined obstruction of the terminal 
ileum and ascending colon (n=2). Compared with proximal 
colonic stenting, a clinical improvement was achieved in 91% 
(90/99) of patients with distal colonic stenting (p=0.08).
3. Complications and subsequent interventions
Stent-related complications occurred in 9 instances for 8 pa-
tients (24%) for SEMSs inserted in the proximal colon obstruc-
tion and 27 cases for insertions in the distal colon obstruction 
(27%, p=0.89). The complications are summarized in Table 4. 
The complications in patients with proximal colonic stenting 
were immediate or delayed bowel perforation related to stenting 
(n=2), stent migration (n=3), and stent reocclusion (n=4).
The stent migration rate did not differ between the two pa-
tients with proximal colon obstruction. In one patient with an 
obstruction in the hepatic flexure, the first stent migrated within 
one day and the reinserted stent also migrated. Nine cases of 
stent migration occurred during chemotherapy. Six patients ex-
perienced no reobstructive symptoms.
Stent reocclusion caused by tumor ingrowth or overgrowth 
occurred in four patients in the proximal colonic stent group 
(11%) at a median of 64 days (range, 19 to 930) and in 18 pa-
tients in the distal colonic stent group (18%) at median of 161 
days (range, 4 to 429). The reocclusion rate and time to stent 
reocclusion did not differ significantly between groups (p=0.47).
All cases of stenting as a bridge to an operation were suc-
cessful clinically. The median time from stenting to curative op-
eration was 7 days (range, 4 to 18) in patients who underwent 
proximal colonic stenting and 6 days (range, 3 to 27) in patients 
who underwent distal colonic stenting. Bowel preparation was 
possible in all patients after stent placement. No major surgi-
cal complications occurred in these patients and none required 
temporary stoma formation.
4. Survival and stent patency
Among the patients who underwent colonic stenting for pal-
liative care, three (11%) with proximal colon obstruction and 
nine (13%) with distal colon obstruction were lost to follow-up 
within one month after stent insertion. In patients who under-
went proximal colonic stenting, the median stent patency was 
120 days (range, 12 to 930 days) and the median survival was 
124 days (range, 12 to 930 days; Fig. 1). In patients who under-
went distal colonic stenting, the median stent patency was 186 
days (range, 3 to 943 days) and the median survival was 348 
days (range, 3 to 943 days; Fig. 2).
DISCUSSION
SEMS placement for palliation is associated with significant 
reductions in hospital stay, mortality and medical complications 
compared with surgery for left-sided malignant colon obstruc-
tion.
12 However, there has been a reluctance to use stents in the 
management of patients with proximal colon lesions primarily 
because such cancers are managed mainly by one-stage surgery 
without the need for bowel preparation or stoma formation. 
We aimed to evaluate the technical feasibility and clinical out-
comes of SEMS placement to treat patients with proximal colon 
obstructions and compared these in patients with distal colon 
obstruction caused by primary colon cancer.
In our study, the clinical improvement in the proximal colon 
obstruction group was not significantly different from the distal 
colon obstruction group (78% vs 91%, p=0.08); however, these 
data seem to be lower than those reported for stenting of the 
Fig. 1. Kaplan-Meier curve of patient survival and stent patency in 
proximal colonic stent placement.
Fig. 2. Kaplan-Meier curve of patient survival and stent patency in 
distal colonic stent placement.Cho YK, et al: Stent in Malignant Proximal Colon Obstruction  169
distal colon. In a systemic review of colorectal stenting—largely 
on distal colonic stents—the median technical success rate was 
96% (range, 67% to 100%) and the median clinical success rate 
was 92% (range, 46% to 100%).
5,13–15 The low rate of clinical im-
provement in the proximal colon obstruction group was mostly 
caused by technical failure of stent insertion. In our study, the 
technical success rate tends to be lower in stents inserted to 
treat a proximal colon obstruction than a distal colon obstruc-
tion (86% vs 97%, p=0.06). Until now, two studies on proxi-
mal colonic stenting reported a 95% technical success rate,
6,16 
similar to those reported for stenting of distal colon lesions.
5 
The 86% technical success rate in this study was lower than 
these two previous studies. The main reasons for technical fail-
ure and higher complication rates were bowel perforation and 
stent expansion failure. Technical failure of SEMSs is caused 
most commonly by an inability to pass the guidewire or stent 
delivery system through an excessively angulated site, such as 
the hepatic flexure, and through a fixated stricture.
16 The long 
distance from the anus and tortuosity of the bowel can prevent 
advancement and positioning of the stent,
17,18 and the poor en-
doscopic view resulting from incomplete bowel preparation can 
disturb access to the obstructive lesion. In this study, most of 
the proximal colon obstructions were complete, and this feature 
might lead to technical failure.
In addition, one important variable determining technical 
or clinical success may be the angulation of the colon. In this 
study, there was one case of stent malposition and one case of 
failure to pass the guidewire, respectively. These patients had 
obstruction at angulated hepatic flexures. The characteristics of 
the lesion is also important. Tumor extension over ascending 
colon to cecum, a cul-de-sac, also can disturb the initial expan-
sion of the stents. 
Bowel perforation is the most serious complication because 
subsequent fecal peritonitis may be fatal. Delayed colonic per-
foration that is not related to the stent insertion procedure itself 
is rare and is usually caused by erosion of the colonic wall by 
the wire ends of the stent at the tumor site.
19–21 In our study, 
the three cases of bowel perforation occurred exclusively in 
patients with proximal colon obstruction. Two cases were re-
lated to the stent and one was not. The first case was caused by 
erosion from the stent over the guidewire deployed through the 
obstruction site in the ascending colon. The second case was 
of a delayed bowel perforation at an ascending colon obstruc-
tion. The wall of the ascending colon is thinner than that of 
the rectum, so the stent might have eroded the wall. This might 
explain the predominance of bowel perforation at a right colon 
obstruction. The third case occurred during balloon dilatation 
followed by stent placement in the transverse colon obstruction. 
In this study, no other patients underwent hydrostatic balloon 
dilatation. Because initial stent expansion was insufficient in 
the second and the third patient, unequal radial force from the 
stent and balloon dilatation might have predisposed to bowel 
perforation.
The tendency of lower technical success and clinical improve-
ment of SEMS in proximal colonic obstruction than in distal co-
lonic obstruction, although not statistically significant, suggests 
the clinically effectiveness of SEMS in the proximal colonic 
obstruction is lower than in distal colonic obstruction.
Colonic stenting as a bridge to surgery allows preoperative 
bowel cleaning and full preoperative staging. It is important for 
reducing the risk of a two-staged operation and perioperative 
complications. In our study, effective colon preparation was 
possible after stent placement in all patients, and none had any 
postsurgical complications.
In our study, the migration rate was 8% in patients receiv-
ing proximal colonic stenting, the same as for distal colonic 
stenting. In most of the patients, the dilating effect of the stent 
on the stricture and the response to chemotherapy persisted for 
some time after migration. The rate of stent reocclusion caused 
by tumor ingrowth or overgrowth and the time until stent reoc-
clusion did not differ significantly between the two groups. 
This multicenter study had extensive long-term follow-up 
data because most of the SEMSs were placed for palliation. The 
median patency of stents used for palliation and the median 
survival in patients receiving proximal colonic stenting did not 
differ from those for the distal colon and are similar to the me-
dian duration of stent patency in a previous study for mainly 
distal colonic stenting.
5 
We included the patients with primary colon cancer exclu-
sively. Our study had some limitations in that it included retro-
spective data and only two types of stents were used. However, 
the features of Hanaro
⡴ stents and Bona
⡴ stents are similar in 
that both stents have a woven structure and high flexibility.
In conclusion, the technical success and clinical improvement 
of SEMS in proximal colonic obstruction tend to be lower in 
distal colonic obstruction, although not statistically significant. 
Technical failure was an important cause of poor clinical im-
provement in patients receiving proximal colonic stenting. The 
complication rate and stent patency seem to be similar in stents 
inserted to treat both a proximal and a distal colonic obstruc-
tion.
REFERENCES
1. Ptok H, Meyer F, Marusch F, et al. Palliative stent implantation in 
the treatment of malignant colorectal obstruction. Surg Endosc 
2006;20:909-914.
2.  Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. 
Pooled analysis of the efficacy and safety of self-expanding metal 
stenting in malignant colorectal obstruction. Am J Gastroenterol 
2004;99:2051-2057.
3.  Khot UP, Lang AW, Murali K, Parker MC. Systematic review of the 
efficacy and safety of colorectal stents. Br J Surg 2002;89:1096-
1102.170  Gut and Liver, Vol. 5, No. 2, June 2011
4.  Mergener K, Kozarek RA. Stenting of the gastrointestinal tract. Dig 
Dis 2002;20:173-181.
5. Watt AM, Faragher IG, Griffin TT, Rieger NA, Maddern GJ. Self-
expanding metallic stents for relieving malignant colorectal ob-
struction: a systematic review. Ann Surg 2007;246:24-30.
6. Repici A, Adler DG, Gibbs CM, Malesci A, Preatoni P, Baron TH. 
Stenting of the proximal colon in patients with malignant large 
bowel obstruction: techniques and outcomes. Gastrointest Endosc 
2007;66:940-944.
7.  Campbell KL, Hussey JK, Eremin O. Expandable metal stent appli-
cation in obstructing carcinoma of the proximal colon: report of a 
case. Dis Colon Rectum 1997;40:1391-1393.
8. García-Cano J, González-Huix F, Juzgado D, et al. Use of self-
expanding metal stents to treat malignant colorectal obstruction 
in general endoscopic practice (with videos). Gastrointest Endosc 
2006;64:914-920.
9. Elsberger B, Rourke K, Brush J, Glancy S, Collie M. Self-expand-
ing metallic stent insertion in the proximal colon. Colorectal Dis 
2008;10:194-196.
10.  Shim CS, Cho JY, Jung IS, et al. Through-the-scope double colonic 
stenting in the management of inoperable proximal malignant 
colonic obstruction: a pilot study. Endoscopy 2004;36:426-431.
11. Dronamraju SS, Ramamurthy S, Kelly SB, Hayat M. Role of self-
expanding metallic stents in the management of malignant ob-
struction of the proximal colon. Dis Colon Rectum 2009;52:1657-
1661.
12.  Carne PW, Frye JN, Robertson GM, Frizelle FA. Stents or open op-
eration for palliation of colorectal cancer: a retrospective, cohort 
study of perioperative outcome and long-term survival. Dis Colon 
Rectum 2004;47:1455-1461.
13.  Wholey MH, Levine EA, Ferral H, Castaneda-Zuniga W. Initial 
clinical experience with colonic stent placement. Am J Surg 
1998;175:194-197.
14. Meisner S, Hensler M, Knop FK, West F, Wille-Jørgensen P. Self-
expanding metal stents for colonic obstruction: experiences from 
104 procedures in a single center. Dis Colon Rectum 2004;47:444-
450.
15.  Binkert CA, Ledermann H, Jost R, Saurenmann P, Decurtins M, 
Zollikofer CL. Acute colonic obstruction: clinical aspects and 
cost-effectiveness of preoperative and palliative treatment with 
self-expanding metallic stents--a preliminary report. Radiology 
1998;206:199-204.
16. Stimac D. Colonic stents for the palliation of malignant colonic 
obstruction. Dig Dis 2008;26:336-341.
17.  Keymling M. Colorectal stenting. Endoscopy 2003;35:234-238.
18. Bhardwaj R, Parker MC. Palliative therapy of colorectal carci-
noma: stent or surgery? Colorectal Dis 2003;5:518-521. 
19.  Camúñez F, Echenagusia A, Simó G, Turégano F, Vázquez J, Bar-
reiro-Meiro I. Malignant colorectal obstruction treated by means 
of self-expanding metallic stents: effectiveness before surgery and 
in palliation. Radiology 2000;216:492-497.
20. Han YM, Lee JM, Lee TH. Delayed colon perforation after pallia-
tive treatment for rectal carcinoma with bare rectal stent: a case 
report. Korean J Radiol 2000;1:169-171.
21. Trovato C, Fiori G, Ravizza D, et al. Delayed colonic perforation 
after metal stent placement for malignant colorectal obstruction. 
Endoscopy 2006;38 Suppl 2:E96.